J&j Recalls Johnson & Johnson - A Essay

J&J Recalls Johnson & Johnson - a Quality Catastrophe

After 50?plus product recalls in 15 months, the $60 billion company is fighting to clear its once-trusted name

In the modern business world, management is often faced with a difficult challenge to find the right balance between short-term profitability and long-term sustainability. Given the intense pressure they face to increase profits and reduce costs, it is often the case that managers will sacrifice sustainability for profitability. This often results in a decrease in quality which can have long-term implications. In the case of Johnson & Johnson, it does not seem like a few managers have made errors on the side of short-term profitability. Rather this position has seemed to permeate much of the organizational culture. Not only does this deviate from the values that the company was founded on, but it also is having a significant detrimental effect on consumer perceptions of the brands value. This report will employ the balanced scorecard approach to generate recommendations of how the company can regain some of the lost consumer confidence due to its quality issues.

Figure 1 - Strategy Map

Financial Perspective

Johnson & Johnson has seemed to lose sight of the sustainable practices that lead to the company's original success. Although every organization is composed of human beings and humans are certainly prone...

...

The CEO in 1982, James Burke, made a bold and ethical decision to recall over thirty one million bottles of Tylenol from the shelves within six days of realizing that there was a possible contamination. This is one of the classical cases of how companies can do the right thing and build intangible goodwill as a result. However, today's J&J apparently had data about some defective well before they stopped marketing these products; which represents a sharp contrast from 1982.
Consumer perceptions of value are of critical importance of to the J&J organization. Retail prices for their products can be double, or more in some cases, that of what the generic alternatives can command. Furthermore, the company also stands to lose a substantial share of loyal customers. Thus the quality issues could cost the company a substantial portion of their market share. Though it is impossible to speculate exactly how much damage will be financially inflicted upon the company, it is reasonable to believe that it is an order of magnitude larger than whatever cost savings they achieved by bypassing quality standards. Thus there is a strong financial incentive for J&J to restore its image in the most expedient manner as possible.

Customer Perspective

When a consumer purchases any one of Johnson & Johnson's products they…

Cite this Document:

"J& J Recalls Johnson & Johnson - A" (2012, February 27) Retrieved April 24, 2024, from
https://www.paperdue.com/essay/j-amp-j-recalls-johnson-amp-johnson-78274

"J& J Recalls Johnson & Johnson - A" 27 February 2012. Web.24 April. 2024. <
https://www.paperdue.com/essay/j-amp-j-recalls-johnson-amp-johnson-78274>

"J& J Recalls Johnson & Johnson - A", 27 February 2012, Accessed.24 April. 2024,
https://www.paperdue.com/essay/j-amp-j-recalls-johnson-amp-johnson-78274

Related Documents

Johnson and Johnson Annual Report Review Financial Report Review Company: Johnson and Johnson Consolidated Balance Sheets Total Assets: $121,347,000,000 Total Liabilities: $56,521,000,000 Total Shareholder's Equity: $64,826,000,000 Company's Retained Earnings: 85,992,000,000 Shares of common stock the company has been authorized to issue: 4,320,000,000 shares Shares the company has issued: 3,119,843,000 shares Cash (cash and cash equivalents): $14,911,000,000 Decrease in cash and cash equivalents during 2012: $9,631,000,000 F: Increase in cash and cash equivalents during 2011: $5,187,000 Consolidated Statement of Earnings Essentially, the term "consolidated" as used

Johnson Bank v. George Korbaken Company Johnson Bank v. George Korbakes Company Over the last several years, the role of the auditor has been continually evolving. This is because financial institutions are relying on the information they are provided with to help them make better choices in the long-term. However, there are times when these firms may not have accurate figures and erroneously report their findings. When this happens, there is a

Johnson and Johnson
PAGES 5 WORDS 1502

Johnson and Johnson Over the last several years, accounting standards and the budgetary process of multinational corporations has been increasingly brought to the forefront. This is because the recent recession and lingering financial challenges, have illustrated how many firms were often over reporting their earnings. As they are using standards that give them more latitude in determining how revenues and expenses are recorded (.i.e. pro-forma). This is when earnings projections and

Johnson Controls Emerging markets are riskier than established ones, and because of that Johnson Controls should make some adjustments to the method by which it evaluates capital investments when dealing in emerging markets. The 2013 Outlook and Strategic Review does not explain how risk is evaluated at Johnson, but the company would normally subject its capital investments to analysis that includes sensitivity analysis, and NPV with sensitivity analysis. For emerging markets, the

Therefore, the claim asserted by Respondents and sustained by the court below would, in practical effect, amount to a right not to be tried at all for an offense against the U.S. armed forces. 339 U.S. 763, 782 (1950). The Court examined the issue of whether the military authorities had jurisdiction to try the offenders. It reasoned that military authorities have had a historical right, during and after hostilities, to

Johnson & Johnson Corporation Johnson and Johnson has been a very broadly-based organization that has been manufacturing health care products since a very long time. It started its footsteps as a child in the mid 1880s with the production of ready-to-use, ready-made surgical dressing. It was the first company to have applied the theory of wound treatment by use of antiseptics. With its application, the chances of infection in postoperative patients